Spain’s competition authority, CNMC, has published a report on the Royal Decree to Regulate the Financing and Price Setting of Medicine and Sanitary Products. The new regulation presented by the Ministry of Health, seeks to regulate two crucial aspects of medication and medical supplies: financing by the National Health Service (SNS) and the prices of each.
Featured News
Papa John’s Wins Final Approval for $5 Million No-Poach Settlement
Aug 18, 2026 by
CPI
Apple Revamps EU App Store Rules in Deal With Regulators
Aug 18, 2026 by
CPI
South Korean Prosecutors Raid Conglomerate Over Alleged Stock Manipulation
Aug 18, 2026 by
CPI
Andreessen Horowitz Faces Justice Department Antitrust Scrutiny Over AI Board Seats
Aug 18, 2026 by
CPI
Disney Sues FCC Over ABC Licenses Over Broadcast Regulation
Aug 18, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes